Literature DB >> 25190496

Targeting the microRNA-regulating DNA damage/repair pathways in cancer.

Giulia Bottai1, Barbara Pasculli, George A Calin, Libero Santarpia.   

Abstract

INTRODUCTION: Maintenance of genome stability requires the integrity of the DNA repair machinery. DNA damage response (DDR) determines cell fate and regulates the expression of microRNAs (miRNAs), which in turn may also regulate important components of the DNA repair machinery. AREAS COVERED: In this review, we describe the bidirectional connection between miRNAs and DDR and their link with important biological functions such as, DNA repair, cell cycle and apoptosis in cancer. Furthermore, we highlight the potential implications of recent findings on miRNA/DDR in determining chemotherapy response in cancer patients, and the use of these biomarkers for novel potential therapeutic approaches. EXPERT OPINION: Defects in the DDR and deregulation of miRNAs are important hallmarks of human cancer. A full understanding of the mechanisms underlying the connection between miRNAs and DDR/DNA repair pathways will positively impact our knowledge on human tumor biology and on different responses to distinct drugs. Specific miRNAs interact with distinct DDR components and are promising targets for enhancing the effects of, and/or to overcome the resistance to, conventional chemotherapeutic agents. Finally, the development of innovative tools to deliver miRNA-targeting oligonucleotides may represents novel types of cancer interventions in clinic.

Entities:  

Keywords:  DNA damage response; DNA repair; apoptosis; cancer therapies; cell cycle; chemotherapy; drug response; microRNAs

Mesh:

Substances:

Year:  2014        PMID: 25190496     DOI: 10.1517/14712598.2014.950650

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  16 in total

Review 1.  Mitotic DNA Damage Response: At the Crossroads of Structural and Numerical Cancer Chromosome Instabilities.

Authors:  Samuel F Bakhoum; Lilian Kabeche; Duane A Compton; Simon N Powell; Holger Bastians
Journal:  Trends Cancer       Date:  2017-02-28

Review 2.  Exploiting microRNAs As Cancer Therapeutics.

Authors:  Tamsin Robb; Glen Reid; Cherie Blenkiron
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

3.  Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.

Authors:  Lijun Zhu; Erich M Sturgis; Hua Zhang; Zhongming Lu; Ye Tao; Qingyi Wei; Guojun Li
Journal:  Int J Cancer       Date:  2017-07-07       Impact factor: 7.396

Review 4.  PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective.

Authors:  Palanisamy Nallasamy; Srinivas Chava; Sumit S Verma; Shruti Mishra; Santhi Gorantla; Don W Coulter; Siddappa N Byrareddy; Surinder K Batra; Subash C Gupta; Kishore B Challagundla
Journal:  Semin Cancer Biol       Date:  2017-11-28       Impact factor: 15.707

5.  Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells.

Authors:  Faizan H Khan; Vijayabaskar Pandian; Satishkumar Ramraj; Sheeja Aravindan; Terence S Herman; Natarajan Aravindan
Journal:  BMC Genomics       Date:  2015-07-07       Impact factor: 3.969

Review 6.  Prognostic value of microRNAs in osteosarcoma: A meta-analysis.

Authors:  Yun Hak Kim; Tae Sik Goh; Chi-Seung Lee; Sae Ock Oh; Jeung Il Kim; Seung Hyeon Jeung; Kyoungjune Pak
Journal:  Oncotarget       Date:  2017-01-31

Review 7.  MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers.

Authors:  Ilaria Plantamura; Giulia Cosentino; Alessandra Cataldo
Journal:  Front Oncol       Date:  2018-09-03       Impact factor: 6.244

8.  Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcoma.

Authors:  Afshin Taheriazam; Amir Jouya Talaei; Mohammad Jamshidi; Mohammadreza Shakeri; Samaneh Khoshbakht; Emad Yahaghi; Marjan Shokrani
Journal:  Diagn Pathol       Date:  2015-10-07       Impact factor: 2.644

Review 9.  Targeting microRNAs as key modulators of tumor immune response.

Authors:  Laura Paladini; Linda Fabris; Giulia Bottai; Carlotta Raschioni; George A Calin; Libero Santarpia
Journal:  J Exp Clin Cancer Res       Date:  2016-06-27

Review 10.  Regulation of DNA Double-Strand Break Repair by Non-Coding RNAs.

Authors:  Roopa Thapar
Journal:  Molecules       Date:  2018-10-27       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.